Multiple Sclerosis Information
Search
I would appreciate a donation. I spend a lot of time every day in researching for articles and the latest research on MS. When an something is written in medical terminology I translate it into non-medical terms. I can no longer work because of my MS.
This Month
July 2009
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31
View Article  Natalizumab associated with pro-inflammatory T cells
Natalizumab is an antibody directed against integrin alpha4 that reduces disease activity in patients with multiple sclerosis (MS) by blocking migration of T and B cells into the Central Nervouse System (CNS). The goal of this study was   more »
View Article  Swine Flu Vaccination 2 of 2
A flurry of innovative vaccine trials is in the offing as governments and regulatory agencies prepare for the probable launch of mass swine flu vaccination programs in the fall. The results of the trials could determine whether people   more »
View Article  Smoking May Equal Rapid Progression of MS
Patients with multiple sclerosis (MS) who smoke appear to experience a more rapid progression of their disease, according to a study published in the July issue of Archives of   more »
View Article  Kineta Acquires Novel Drug Candidates from Airmid
Kineta, Inc. of Seattle and Airmid Incorporated of Redwood City, CA jointly announce an agreement in which a Kineta subsidiary has acquired exclusive commercial rights to a portfolio of novel therapeutic compounds from Airmid. The array of compounds holds extraordinary potential   more »
View Article  phase III trial of Mylinax (oral cladribine)
Over the two-year period of the study, 80% of the low dose regimen Cladribine arm and 79% of the high-dose regimen arm experienced no clinical relapse, compared with 61% of the   more »
View Article  Drug Trial - Female Stress Urinary Incontinence
Over 11 million women in the United States suffer from stress urinary incontinence (SUI), the involuntary leakage of urine during routine physical activities such as laughing, coughing, exercising, or sneezing. SUI affects women   more »
View Article  U.S. Study Will Test Vitamin D, Fish Oil
Two of the most popular and promising dietary supplements -- vitamin D and fish oil -- will be tested in a large, government-sponsored study to see whether either nutrient can lower a healthy person's risk of getting cancer   more »
View Article  Oral Laquinimod Phase III MS Clinical Trial
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced completion of patient enrollment for the second pivotal Phase III clinical trial, BRAVO, evaluating the novel, oral once-daily immunomodulating   more »
View Article  New Theory for Why Repair of the Brain’s Wiring Fails
Scientists have uncovered new evidence suggesting that damage to nerve cells in people with multiple sclerosis (MS) accumulates because the body’s natural mechanism for repairing the nerve coating   more »
View Article  Study - Spasticity
This research study will evaluate a treatment for moderate to severe spasticity associated with MS. All patients must have been on baclofen for at least four weeks prior to first visit. This study requires   more »
View Article  Study - Restless Legs
Discomfort or pain in your legs which worsens at night or when resting A strong urge to move your legs for relief Itching, pulling, creepy-crawly, tugging, or gnawing   more »
View Article  Autoinjection Device Appears subcutaneous injections of interferon beta (IFNB)-1a
A new electronic, multidose, autoinjection device improves subcutaneous delivery of interferon beta (IFNB)-1a in patients with relapsing multiple sclerosis (MS), according to a study presented here at the 19th Meeting of the European   more »
View Article  Cognitive function Improved by disease-modifying therapies
Patients with relapsing-remitting multiple sclerosis (RRMS) who receive glatiramer acetate (GA) or interferon (IFN) beta show a reduction in cognitive impairment and relative stability of cognitive and affective variables at 2 years, according to the results of an observational study presented   more »
View Article  Richer Source for Stem Cells = Placentas?
The human placenta could be an important source of stem cells for curing leukemia, sickle cell disease and other blood-related disorders, a new study reveals. These stem cells appear to have distinct advantages over the techniques currently used to fight such diseases, and they   more »
View Article  Clinical Study – Volunteers Needed 2
This is an early phase study designed to test the safety of a compound. This is one of the steps necessary before conducting a large clinical trial to determine if the agent ONO-4641 is effective in MS.   Main Eligibility R   more »